摘要
Colorectal cancer (CRC) accounts for approximately 10% of newly diagnosed cancer cases and cancer-related deaths worldwide~1. The identification of molecular subtypes of CRCs has significantly advanced treatment strategies,including targeted therapy and immunotherapy.
基金
supported by grants from the National Natural Science Foundation of China (Grant No.81972702)
the Beijing Nova Program (Grant No. 2022029)。
